Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease and type 2 diabetes mellitus

Julia M. Janssen, William L. Heyward, Jacob T. Martin, Robert S. Janssen

Vaccine · 2015 · 40 citations · 9 references

Concepts

References

9